BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 20687111)

  • 1. Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.
    Lipina TV; Kaidanovich-Beilin O; Patel S; Wang M; Clapcote SJ; Liu F; Woodgett JR; Roder JC
    Synapse; 2011 Mar; 65(3):234-48. PubMed ID: 20687111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic interactions between PDE4B and GSK-3: DISC1 mutant mice.
    Lipina TV; Wang M; Liu F; Roder JC
    Neuropharmacology; 2012 Mar; 62(3):1252-62. PubMed ID: 21376063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic inactivation of GSK3α rescues spine deficits in Disc1-L100P mutant mice.
    Lee FH; Kaidanovich-Beilin O; Roder JC; Woodgett JR; Wong AH
    Schizophr Res; 2011 Jun; 129(1):74-9. PubMed ID: 21498050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic valproic acid treatment prevents schizophrenia-related behaviour in Disc1-L100P mutant mice.
    Lipina TV; Haque FN; McGirr A; Boutros PC; Berger T; Mak TW; Roder JC; Wong AH
    PLoS One; 2012; 7(12):e51562. PubMed ID: 23272119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive behavioral analysis of ENU-induced Disc1-Q31L and -L100P mutant mice.
    Shoji H; Toyama K; Takamiya Y; Wakana S; Gondo Y; Miyakawa T
    BMC Res Notes; 2012 Feb; 5():108. PubMed ID: 22348257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia.
    Lipina TV; Niwa M; Jaaro-Peled H; Fletcher PJ; Seeman P; Sawa A; Roder JC
    Genes Brain Behav; 2010 Oct; 9(7):777-89. PubMed ID: 20618446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice.
    Lipina TV; Zai C; Hlousek D; Roder JC; Wong AH
    J Neurosci; 2013 May; 33(18):7654-66. PubMed ID: 23637159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dopamine D2 receptor-DISC1 protein complex may contribute to antipsychotic-like effects.
    Su P; Li S; Chen S; Lipina TV; Wang M; Lai TK; Lee FH; Zhang H; Zhai D; Ferguson SS; Nobrega JN; Wong AH; Roder JC; Fletcher PJ; Liu F
    Neuron; 2014 Dec; 84(6):1302-16. PubMed ID: 25433637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of background mutations and single nucleotide polymorphisms (SNPs) on the Disc1 L100P behavioral phenotype associated with schizophrenia in mice.
    Arime Y; Fukumura R; Miura I; Mekada K; Yoshiki A; Wakana S; Gondo Y; Akiyama K
    Behav Brain Funct; 2014 Dec; 10():45. PubMed ID: 25487992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal interneuron development in disrupted-in-schizophrenia-1 L100P mutant mice.
    Lee FH; Zai CC; Cordes SP; Roder JC; Wong AH
    Mol Brain; 2013 Apr; 6():20. PubMed ID: 23631734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missense mutation in DISC1 C-terminal coiled-coil has GSK3β signaling and sex-dependent behavioral effects in mice.
    Dachtler J; Elliott C; Rodgers RJ; Baillie GS; Clapcote SJ
    Sci Rep; 2016 Jan; 6():18748. PubMed ID: 26728762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral phenotypes of Disc1 missense mutations in mice.
    Clapcote SJ; Lipina TV; Millar JK; Mackie S; Christie S; Ogawa F; Lerch JP; Trimble K; Uchiyama M; Sakuraba Y; Kaneda H; Shiroishi T; Houslay MD; Henkelman RM; Sled JG; Gondo Y; Porteous DJ; Roder JC
    Neuron; 2007 May; 54(3):387-402. PubMed ID: 17481393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic β-cell function via glycogen synthase kinase-3β.
    Jurczyk A; Nowosielska A; Przewozniak N; Aryee KE; DiIorio P; Blodgett D; Yang C; Campbell-Thompson M; Atkinson M; Shultz L; Rittenhouse A; Harlan D; Greiner D; Bortell R
    FASEB J; 2016 Feb; 30(2):983-93. PubMed ID: 26546129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disrupted in schizophrenia 1 (DISC1) L100P mutants have impaired activity-dependent plasticity in vivo and in vitro.
    Tropea D; Molinos I; Petit E; Bellini S; Nagakura I; O'Tuathaigh C; Schorova L; Mitchell KJ; Waddington J; Sur M; Gill M; Corvin AP
    Transl Psychiatry; 2016 Jan; 6(1):e712. PubMed ID: 26756905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DISC1 R264Q variant increases affinity for the dopamine D2 receptor and increases GSK3 activity.
    Su P; Zhang H; Wong AHC; Liu F
    Mol Brain; 2020 Jun; 13(1):87. PubMed ID: 32493513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of human truncated DISC1 proteins: implications for schizophrenia.
    Newburn EN; Hyde TM; Ye T; Morita Y; Weinberger DR; Kleinman JE; Lipska BK
    Transl Psychiatry; 2011 Aug; 1(8):e30. PubMed ID: 22832604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results.
    Bersudsky Y; Shaldubina A; Kozlovsky N; Woodgett JR; Agam G; Belmaker RH
    Behav Pharmacol; 2008 May; 19(3):217-24. PubMed ID: 18469539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peculiarities of the Composition of Peripheral Immune Cells and Cytokine Profile in Brain Structures in Mutant DISC1-L100P Mice.
    Al'perina EL; Gevorgyan MM; Zhanaeva SY; Lipina TV; Idova GV
    Bull Exp Biol Med; 2021 Jul; 171(3):347-351. PubMed ID: 34297294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epistatic and Independent Effects on Schizophrenia-Related Phenotypes Following Co-disruption of the Risk Factors Neuregulin-1 × DISC1.
    O'Tuathaigh CM; Fumagalli F; Desbonnet L; Perez-Branguli F; Moloney G; Loftus S; O'Leary C; Petit E; Cox R; Tighe O; Clarke G; Lai D; Harvey RP; Cryan JF; Mitchell KJ; Dinan TG; Riva MA; Waddington JL
    Schizophr Bull; 2017 Jan; 43(1):214-225. PubMed ID: 27613806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model.
    Pogorelov VM; Nomura J; Kim J; Kannan G; Ayhan Y; Yang C; Taniguchi Y; Abazyan B; Valentine H; Krasnova IN; Kamiya A; Cadet JL; Wong DF; Pletnikov MV
    Neuropharmacology; 2012 Mar; 62(3):1242-51. PubMed ID: 21315744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.